Grants per year
Grants 2010 2021
Finished
Prot# EN3348-303: A Phase 3, Randomized, Active-Controlled, Open-Label, Multicenter Study to Evaluate the Efficacy and Safety of EN3348(MCC) as Compared with Mitomycin C in the Intravesical Treatment of Subjects wit BCG Recurrent or Refractory Non-Muscle
Clinical Financial Services, LLC, Endo Pharmaceuticals Inc
2/2/12 → 2/2/15
Project: Research project
Utility-Assessment for Co-Morbidities in Prostate Cancer
University of Chicago, National Cancer Institute
7/2/10 → 6/30/12
Project: Research project